Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_assertion type Assertion NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_head.
- NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_assertion description "[Treatment of breast cancer cells with CDK inhibitors (flavopiridol; roscovitine) enhanced the lethality of the ERBB1 inhibitor lapatinib in a synergistic fashion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_provenance.
- NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_assertion evidence source_evidence_literature NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_provenance.
- NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_assertion SIO_000772 20855960 NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_provenance.
- NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_assertion wasDerivedFrom befree-2016 NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_provenance.
- NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_assertion wasGeneratedBy ECO_0000203 NP840540.RAM4aY9eS_eRM0-x_8w1rrQTtIGs4ipwM3Mi3IThPZcNY130_provenance.